EUVIMEDEUVIMED entdecken
Systematische ÜbersichtFallbericht

Expanding the Clinical Spectrum of NR4A2 ‐Related Disorder: A Systematic Literature Review and Case Series

Chloe Borden iD, Muhammad Bin Nasir, Mary-Beth Roberts, Lauren Palange, Xiangling Wang

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64145 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Chloe Borden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Nuclear Receptor Subfamily 4, Group A, Member 2, Intellectual Disability, Neurodevelopmental Disorders, Developmental Disabilities. Die Arbeit nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NR4A2 encodes a nuclear transcription factor in the steroid‐thyroid hormone‐retinoid receptor family. Pathogenic variants in NR4A2 are rare and until now have been associated exclusively with neurodevelopmental phenotypes. A systematic literature review of NR4A2 ‐related disorder was conducted using the PubMed and ClinVar databases. We also report two novel cases. Twenty‐eight PubMed records and 55 ClinVar reports were screened, and 16 studies were included in the final report. Thirty‐two patients with 31 unique pathogenic variants in NR4A2 have been reported. This cohort is 53% female with a median age of 12 years (IQR 8–25). The neurodevelopmental phenotypic spectrum included intellectual disability and/or developmental delay in 93%, language impairment in 63%, recurrent seizures or epilepsy in 41%, and movement disorders in 31%. Extra‐neurologic phenotypes were present in 47% and included craniofacial dysmorphism in 25%, musculoskeletal anomalies in 28%, gastrointestinal anomalies in 19%, and renal anomalies in 6%. Endocrine anomalies and dysregulated glucose and lipid metabolism were present exclusively in our two novel cases. The clinical spectrum of NR4A2 ‐related disorder is likely much broader and more heterogeneous than originally suspected. This heterogeneity has likely contributed to under‐detection of NR4A2 pathogenic variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Receptor Subfamily 4, Group A, Member 2Intellectual DisabilityNeurodevelopmental DisordersDevelopmental DisabilitiesGenetic Predisposition to DiseaseHumansFemalePhenotypeChildMaleAdolescentMutationAdultYoung AdultEpilepsy

Stichwörter der Autor:innen

cystic kidney diseaseendocrine abnormalitiesneurodevelopmental disordersnuclear receptor 4A2 (NR4A2) related disorderskeletal abnormalities

Substanzen

Nuclear Receptor Subfamily 4, Group A, Member 2NR4A2 protein, human

Autor:innen und Institutionen

  • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
  • Aga Khan University College of Medicine, Karachi, Pakistan.
  • Department of Medical Genetics and Genomics, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Molecular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Chloe Borden

Zitieren

APA

Borden, C., Nasir, M. B., Roberts, M. B., Palange, L., & Wang, X. (2025). Expanding the Clinical Spectrum of NR4A2 ‐Related Disorder: A Systematic Literature Review and Case Series. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64145

Vancouver

Borden C, Nasir MB, Roberts MB, Palange L, Wang X. Expanding the Clinical Spectrum of NR4A2 ‐Related Disorder: A Systematic Literature Review and Case Series. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64145

BibTeX
@article{Borden2025,
  author = {Borden, Chloe and Nasir, Muhammad Bin and Roberts, Mary-Beth and Palange, Lauren and Wang, Xiangling},
  title = {Expanding the Clinical Spectrum of NR4A2 ‐Related Disorder: A Systematic Literature Review and Case Series},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64145}
}
Kostenlos starten →